Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-28

Clinical Trial Update: Evaluation 2% Chlorhexidine Gluconate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 2% chlorhexidine gluconate for skin coverage completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 2% chlorhexidine gluconate (chlorhexidine gluconate)

Snippet

Sponsor: Medline Industries | Conditions: Skin Coverage | Phase 2 | Status: COMPLETED | Results posted: 2023-09-28